“…Several studies [3][4][5][6][7][8][9] have reported persistent symptoms, as well as radiologic and functional abnormalities during follow-up several weeks or months after hospital discharge, but the prevalence and severity of the longterm sequelae of SARS remain largely unknown. Because lung function is known to improve for up to 1 year after discharge from the hospital in survivors of other causes of acute lung injury, 10,11 it is imperative that long-term studies of SARS survivors be conducted in order to determine the persistence of abnormalities in pulmonary function, and whether these abnormalities contribute to permanent impairment and disability. As the majority of patients with SARS survive the illness 2 and medical personnel, physicians, nurses, and hospital workers are among those commonly infected in most countries, 2 an additional requisite for the identification and quantification of morbidity among survivors may be for the consideration of awarding compensation.…”